High CD204+ tumor-infiltrating macrophage density predicts a poor prognosis in patients with urothelial cell carcinoma of the bladder.

bo wang,hao liu,xiaoliang dong,shaoxu wu,hong zeng,zhuowei liu,di wan,wen dong,wang he,xu chen,limin zheng,jian huang,tianxin lin
DOI: https://doi.org/10.18632/oncotarget.3887
2015-01-01
Oncotarget
Abstract:Macrophages (M phi s) are a major cell type that can infiltrate solid tumors and exhibit distinct phenotypes in different tumor microenvironments. This study attempted to investigate the prognostic values of various tumor-infiltrating M phi phenotypes in patients with urothelial cell carcinoma of the bladder (UCB), with a focus on M phi tissue microlocalization. M phi s were assessed by immunohistochemistry in tissues from 302 UCB patients using CD68 as a pan-M phi marker, and CD204 and CD169 as robust pro-and anti-tumoral M phi phenotype markers, respectively. Our data showed that these M phi phenotypes were predominately distributed in stromal (ST) rather than in intratumoral (INT) regions (all P < 0.0001). Surprisingly, CD204 and CD169 can be co-expressed by the same CD68(+) M phi s. Kaplan-Meier analysis revealed that all INT-and ST-infiltrating CD204(+) or CD169(+) M phi densities were inversely associated with overall survival (all P < 0.01). By multivariate analysis, ST-infiltrating CD204(+) M phi density emerged as an independent prognostic factor for overall survival (HR, 1.981; P = 0.022). Moreover, the density of ST-infiltrating CD204(+) M phi s was positively associated with the tumor size (P = 0.001), tumor stage (P < 0.0001), nodal metastasis (P < 0.0001), and histological grade (P < 0.0001). Our findings suggest that CD204(+) M phi s might play detrimental protumoral roles and represent the predominant M phi phenotype in human bladder cancer.
What problem does this paper attempt to address?